Coronavirus (COVID-19): Legal Resources

Advisories and Webinars

• Antitrust

  Advisories

  • EU Emergency State Aid Programs to Enable EU Member States to Support Businesses in the COVID-19 Outbreak | March 24, 2020 (Updated April 14, 2020)
  • COVID-19 Puts Spotlight on Price Gouging | April 10, 2020
  • European Antitrust: Competition Authorities Across Europe and Across the World Move to Clarify Permissible Cooperation to Respond to the COVID-19 Crisis | March 30, 2020
  • US Antitrust: FTC and DOJ Release Joint Antitrust Statement Announcing Expedited Review and Policy Guidance Regarding Collaborations Related to COVID-19 | March 27, 2020
  • FTC Announces Suspension of Early Terminations of the Waiting Period Under the HSR Act and Temporary E-Filing Procedures | March 13, 2020
• Corporate Operations and Governance

  Advisories

  • Considerations for Acquisitions and Investments Involving Companies That Have Taken CARES Act Funding | May 27, 2020
  • NYSE Provides Additional Relief from its Shareholder Approval Requirements for Specified Private Placements Through June 30, 2020 | May 20, 2020
  • NASDAQ Suspends Shareholder Approval Requirements for Specified Private Placements | May 7, 2020
  • SEC Staff Issues FAQs Pertaining to Its Order Extending Certain Filing Deadlines | May 6, 2020
  • NYSE and NASDAQ Respond to COVID-19 | May 4, 2020
  • Sycamore Partners Terminates its Agreement to Acquire a Majority Interest in Victoria's Secret Based on the Target's Response to COVID-19 | April 23, 2020
  • Today's Judgments, Tomorrow's Enforcement: Accounting and Business Judgments Most Vulnerable to Hindsight | April 15, 2020
  • First Quarter Disclosure Considerations for Publicly Traded Financial Institutions | April 9, 2020
  • Legal Considerations in a Negative Interest Rate Environment | March 30, 2020
  • SEC Staff Expresses Its Views on COVID-19 Disclosures as Earnings Season Commences; Exemptive Relief Extended for Filings with Deadlines on or Before July 1, 2020 | March 27, 2020
  • SEC Staff Statement Regarding Manual Signatures in Light of COVID-19 Concerns | March 25, 2020
  • NYS Temporarily Lifts Prohibition on Virtual-Only Annual Meetings | March 23, 2020
  • Coronavirus (COVID-19): How to Respond to Distress in Your Business | March 22, 2020
  • Considerations for Conducting Annual Meetings in Light of COVID-19 Concerns | March 17, 2020
  • SEC Issues Exemptive Order Relating to Coronavirus | March 6, 2020
• Employment and Privacy

  Advisories

  • University Preparedness for a Pandemic: Key Testing and Privacy Considerations Every University Should Be Aware Of | June 18, 2020
  • Paycheck Protection Program Flexibility Act | June 5, 2020
  • HEROES IN THE HOUSE: Congress Begins Consideration of a 5th COVID-19 Response Package Totaling $3 Trillion in New Spending | May 14, 2020
  • Returning Employees to Work: What Should US Employers Think About? | May 4, 2020
  • Preparing for a Return to the Workplace: What Issues May UK Employers Face? | May 4, 2020
  • Employee Privacy With Respect to COVID-19 | April 2, 2020
  • Coronavirus Legislative Update: The CARES Act Becomes Law | March 26, 2020
  • Coronavirus and Declining Work—What Options Are Open to UK Employers? | March 25, 2020
  • DOL Issues First Guidance on Paid Sick Leave and Expanded Family and Medical Leave Under the Families First Coronavirus Response Act | March 25, 2020
  • California Employers Who Shut Down or Conducted a Mass Layoff on or After March 4 Must Still Provide Notice Under Cal-WARN to Take Advantage of Executive Order | March 24, 2020
  • California Suspends State WARN Law Amid COVID-19 Pandemic | March 18, 2020
  • Families First Coronavirus Response Act Signed Into Law by President Trump, Will Take Effect No Later Than April 2, 2020 | March 18, 2020
  • Coronavirus Legislative Update | March 16, 2020
  • Pandemic Coronavirus: Practical and Legal Issues for Employers | March 6, 2020

  Webinars

  • Re-Opening Your Business in a COVID Environment: A Discussion on Protecting Consumers and Employees | June 22, 2020
  • Policy Developments Related to the Coronavirus Pandemic Part II: The CARES Act | March 27, 2020
  • The Coronavirus Crisis: What Companies Need to Know About Congressional Actions to Date and the Likely Next Legislative Steps on the Road to Recovery | March 18, 2020
• Enforcement and Litigation

  Advisories

  • Lender Involvement in PPP Fraud Investigations | June 9, 2020
  • Considerations for Acquisitions and Investments Involving Companies That Have Taken CARES Act Funding | May 27, 2020
  • HEROES IN THE HOUSE: Congress Begins Consideration of a 5th COVID-19 Response Package Totaling $3 Trillion in New Spending | May 14, 2020
  • Litigation and Regulatory Concerns for Compliance-Oriented Lenders Who Make Paycheck Protection Program Loans | May 8, 2020
  • Fraud in the Time of COVID-19: White Collar and Regulatory Enforcement of the CARES Act | May 6, 2020
  • Sycamore Partners Terminates Its Agreement to Acquire a Majority Interest in Victoria's Secret Based on the Target's Response to COVID-19 | April 23, 2020
  • Today's Judgments, Tomorrow's Enforcement: Accounting and Business Judgments Most Vulnerable to Hindsight | April 15, 2020
  • COVID-19 Puts Spotlight on Price Gouging | April 10, 2020
  • Coronavirus Legislative Update: The CARES Act Becomes Law | March 26, 2020
  • Litigation Advisory: Guidance for In-House Litigation Counsel Regarding COVID-19 | March 25, 2020
  • Insider Trading on Political Intelligence: Challenges to Prosecuting Sitting Legislators | March 24, 2020
  • What to Do When You Receive a Coronavirus-Related Force Majeure Notice | March 4, 2020

  Webinars

  • FCA Exposure in the Age of COVID—How to Distance Yourself From Liability | June 24, 2020
  • Navigating COVID-19 Related Congressional Investigations | May 21, 2020
  • COVID-19: Keeping Consumers Safe—and Your Company Safer—in a Changing, Challenging Environment | April 8, 2020
  • Preparing for the Altered Litigation Landscape | April 3, 2020
  • Policy Developments Related to the Coronavirus Pandemic Part II: The CARES Act | March 27, 2020
• Environmental

  Advisories

  • Executive Order on Regulatory Relief Issued to Support Economic Recovery | June 4, 2020
  • Environmental Financial Assurance After COVID-19 | April 27, 2020
  • EPA Issues Interim COVID-19 Guidance For Decisions to Delay Field-Work at Environmental Cleanup Sites | April 10, 2020
  • Trump's Environmental Regulatory and Deregulatory Agenda at Risk Due to COVID-19 | April 8, 2020
  • EPA's Office of Enforcement and Compliance Assurance Issues Temporary COVID-19 Guidance | March 27, 2020
  • Disinfecting for COVID-19: The Role of the US Environmental Protection Agency | March 17, 2020
  • Emergency Exemptions From Environmental Laws Applicable to the Coronavirus Pandemic | March 16, 2020

  Webinar

  • Re-Opening Your Business in a COVID Environment: A Discussion on Protecting Consumers and Employees | June 22, 2020
  • COVID-19: Implications for the Environmental Regulatory and Enforcement Landscape | April 21, 2020
• Financial Markets

  Advisories

  • Lender Involvement in PPP Fraud Investigations | June 9, 2020
  • Executive Order on Regulatory Relief Issued to Support Economic Recovery | June 4, 2020
  • NYSE Provides Additional Relief from its Shareholder Approval Requirements for Specified Private Placements Through June 30, 2020 | May 20, 2020
  • HEROES IN THE HOUSE: Congress Begins Consideration of a 5th COVID-19 Response Package Totaling $3 Trillion in New Spending | May 14, 2020
  • NASDAQ Suspends Shareholder Approval Requirements for Specified Private Placements | May 7, 2020
  • Federal Reserve Expands Main Street Lending Program | May 7, 2020
  • SEC Staff Issues FAQs Pertaining to Its Order Extending Certain Filing Deadlines | May 6, 2020
  • NYSE and NASDAQ Respond to COVID-19 | May 4, 2020
  • Sovereign Bond Issues During the Pandemic: Practical Considerations for Debt Management Offices | April 22, 2020
  • Financial Services and Financing Reforms to Address the Economic Impact of the COVID-19 Pandemic | April 17, 2020
  • Term Asset-Backed Securities Loan Facility | April 17, 2020
  • SEC Chairman Holds Firm on June 30, 2020 Reg. BI Compliance Deadline | April 14, 2020
  • First Quarter Disclosure Considerations for Publicly Traded Financial Institutions | April 9, 2020
  • COVID-19: The Response of the International Financial Institutions and Some Considerations for Sovereign Debt Management Officers | April 7, 2020
  • Legal Considerations in a Negative Interest Rate Environment | March 30, 2020
  • Key Issues in Loan Agreements Relating to the COVID-19 Pandemic | March 23, 2020
  • Managing Capital Markets Debt Obligations in the Coronavirus Crisis: A Liability Management Primer | March 23, 2020
  • Considerations for US Publicly Traded Bank Holding Companies Considering Share Buybacks During Coronavirus Pandemic | March 19, 2020
  • Financial Regulators Encourage and Expect Firms to Continue Assisting Businesses During the Coronavirus Pandemic | March 17, 2020

  Webinar

  • CARES Act/Federal Reserve Act Section 13(3): Weekly Update 7 | June 26, 2020
  • CARES Act/Federal Reserve Act Section 13(3): Weekly Update 6 | June 12, 2020
  • CARES Act/Federal Reserve Act Section 13(3): Weekly Update 5 | June 5, 2020
  • CARES Act/Federal Reserve Act Section 13(3): Weekly Update 4 | May 29, 2020
  • CARES Act/Federal Reserve Act Section 13(3): Weekly Update 3 | May 22, 2020
  • Navigating COVID-19 Related Congressional Investigations | May 21, 2020
  • Policymaker Speaker Series: Featuring US Representatives Joyce Beatty (D-OH) and Steve Stivers (R-OH) | May 20, 2020
  • CARES Act/Federal Reserve Act Section 13(3): Weekly Update 2 | May 15, 2020
  • CARES Act/Federal Reserve Act Section 13(3) Weekly Update: MSLP, PMCCF and PPP | May 8, 2020
  • COVID-19: An Overview of Emergency Financing Facilities Created Under the Cares Act and Section 13(3) of the Federal Reserve Act | May 1, 2020
• Global Law

  Advisories

  • COVID-19 Contact-Tracing Apps: What Privacy Law Will Apply? | June 10, 2020
  • Executive Order on Regulatory Relief Issued to Support Economic Recovery | June 4, 2020
  • COVID-19: How Employers Can Handle the Crisis and Prepare for a Return to Work | May 11, 2020
  • Enforcement Agencies Grant Temporary Trade Sanctions and ITAR Compliance Relief Due to COVID-19 | May 8, 2020
  • Preparing for a Return to the Workplace: What Issues May UK Employers Face? | May 4, 2020
  • Sovereign Bond Issues During the Pandemic: Practical Considerations for Debt Management Offices | April 22, 2020
  • EU Emergency State Aid Programs to Enable EU Member States to Support Businesses in the COVID-19 Outbreak | March 24, 2020 (Updated April 14, 2020)
  • COVID-19: The Response of the International Financial Institutions and Some Considerations for Sovereign Debt Management Officers | April 7, 2020
  • UK Relief Package Supports the Economy, Large Corporates and Small Businesses Reeling From COVID-19 | April 7, 2020
  • European Antitrust: Competition Authorities Across Europe and Across the World Move to Clarify Permissible Cooperation to Respond to the COVID-19 Crisis | March 30, 2020
  • Latest Guidance of the EMA and European and UK National Authorities on Crisis Management of Clinical Trials and Medicine Supplies During the COVID-19 Pandemic | March 27, 2020
  • Coronavirus and Declining Work—What Options Are Open to UK Employers? | March 25, 2020
  • "Do Not Travel": FAQ on The Coronavirus Travel Advisory | March 22, 2020
  • European Commission Approves First COVID-19 State Aid Scheme Within 24 Hours: Germany Announces Measures to Assist German Businesses | March 19, 2020
  • Help in a Time of COVID-19: Providing Humanitarian Assistance to Those in Need in Countries Subject to US Economic Sanctions | March 18, 2020
  • FAQ on the Coronavirus European Travel Ban | March 13, 2020
  • What to Do When You Receive a Coronavirus-Related Force Majeure Notice | March 4, 2020

  Blog Posts

  • The European Commission proposes a Regulation for COVID-19 clinical trials conducted with medicinal products containing or consisting of GMOs | July 9, 2020
  • EU Medical Devices Regulation: implementation progress during the pandemic | June 18, 2020
  • EMA Guidance on fast-tracking the development and approval of treatments and vaccines for COVID-19 | May 7, 2020
  • UK Government Offers IP Indemnity to Designers and Manufacturers of Ventilators for COVID-19 Patients | April 24, 2020

  Webinar

  • EU and UK Compliance Considerations in Remote Promotion Training and Medical Information Services | July 2, 2020
  • Pharmaceutical and Medical Device Global Supply Chains Under a Microscope: Understanding and Managing the Growing Risks | June 25, 2020
• Government Contracting and Supply Chain

  Advisories

  • Strategic National Stockpile 2.0: The Department of Health and Human Services Issues Request for Information Relating to the Strategic National Stockpile | May 20, 2020
  • HEROES IN THE HOUSE: Congress Begins Consideration of a 5th COVID-19 Response Package Totaling $3 Trillion in New Spending | May 14, 2020
  • 3D Printing in the Fight Against COVID-19: The Shifting Legal Landscape | April 27, 2020
  • FEMA Issues Additional Exemptions to Restrictions on Export of PPE Under the Defense Production Act | April 23, 2020
  • Department of Defense Clarifies Implementation of CARES Act Section 3610 to Provide Contractors Relief for Paid Leave | April 16, 2020
  • DoD Implements Section 3610 of CARES Act by Converting It Into a Cost Principle: Reflections and Best Practices | April 9, 2020
  • For Domestic Use Only: FEMA Issues Temporary Final Rule Implementing Export Restrictions of PPE Under The Defense Production Act | April 9, 2020
  • The Coronavirus Crisis—Consider Your Contract Notice Provisions in Light of Office Closures | March 22, 2020
  • The President Invokes the Defense Production Act in Response to COVID-19 | March 18, 2020
  • The Public Readiness and Emergency Preparedness (PREP) Act: Liability Protection for Suppliers of COVID-19 Countermeasures | March 16, 2020
  • Preparing for the Impact of the Coronavirus on Your Supply Chain and Beyond | March 12, 2020
  • Prepare, Communicate, Document, and Segregate—A Government Contractor's Guide to Addressing Performance Disruptions and Delays Related to COVID-19 | March 11, 2020
  • What to Do When You Receive a Coronavirus-Related Force Majeure Notice | March 4, 2020

  Webinars

  • Understanding and Leveraging the Defense Production Act | May 18, 2020
  • COVID-19: Working With BARDA and FDA on COVID-19 Countermeasures | March 26, 2020
• Government Financial Relief

  Advisories

  • Small Business Administration Releases New and Revised Loan Forgiveness Applications to Implement Terms of the Paycheck Protection Program Flexibility Act | June 24, 2020
  • Lender Involvement in PPP Fraud Investigations | June 9, 2020
  • Paycheck Protection Program Flexibility Act | June 5, 2020
  • Considerations for Acquisitions and Investments Involving Companies That Have Taken CARES Act Funding | May 27, 2020
  • HEROES IN THE HOUSE: Congress Begins Consideration of a 5th COVID-19 Response Package Totaling $3 Trillion in New Spending | May 14, 2020
  • Federal Reserve Expands Main Street Lending Program | May 7, 2020
  • Fraud in the Time of COVID-19: White Collar and Regulatory Enforcement of the CARES Act | May 6, 2020
  • EU Emergency State Aid Programs to Enable EU Member States to Support Businesses in the COVID-19 Outbreak | March 24, 2020 (Updated April 14, 2020)
  • The CARES Act: Income Tax Provisions for Businesses | April 7, 2020
  • UK Relief Package Supports the Economy, Large Corporates and Small Businesses Reeling From COVID-19 | April 7, 2020
  • Small Business Loan Relief From CARES Act | March 30, 2020
  • Coronavirus Legislative Update: The CARES Act Becomes Law | March 26, 2020
  • Coronavirus Legislative Update | March 16, 2020

  Webinars

  • Policy Developments Related to the Coronavirus Pandemic Part II: The CARES Act | March 27, 2020
  • The Coronavirus Crisis: What Companies Need to Know About Congressional Actions to Date and the Likely Next Legislative Steps on the Road to Recovery | March 18, 2020
• Healthcare and Life Sciences

  Advisories

  • PREP Act Declaration Amended to Clarify Coverage of Products Used to "Limit the Harm" From COVID-19 | June 11, 2020
  • Executive Order on Regulatory Relief Issued to Support Economic Recovery | June 4, 2020
  • FDA Issues Guidance on New Medical Device Shortage Reporting Requirements | June 1, 2020
  • Strategic National Stockpile 2.0: The Department of Health and Human Services Issues Request for Information Relating to the Strategic National Stockpile | May 20, 2020
  • HEROES IN THE HOUSE: Congress Begins Consideration of a 5th COVID-19 Response Package Totaling $3 Trillion in New Spending | May 14, 2020
  • 3D Printing in the Fight Against COVID-19: The Shifting Legal Landscape | April 27, 2020
  • FEMA Issues Additional Exemptions to Restrictions on Export of PPE Under the Defense Production Act | April 23, 2020
  • HHS Issues Advisory Opinion Addressing PREP Act Immunity Issues | April 22, 2020
  • COVID-19 Puts Spotlight on Price Gouging | April 10, 2020
  • Personal Health Information Privacy and COVID-19: HIPAA and California Law Enforcement Forbearance | April 8, 2020
  • Medicare and FCC Take Additional Steps to Support the Frontline Battling COVID-19 | April 8, 2020
  • Latest Guidance of the EMA and European and UK National Authorities on Crisis Management of Clinical Trials and Medicine Supplies During the COVID-19 Pandemic | March 27, 2020
  • Coronavirus Legislative Update: The CARES Act Becomes Law | March 26, 2020
  • Expanding Telehealth Services to Fight COVID-19 | March 20, 2020
  • The President Invokes the Defense Production Act in Response to COVID-19 | March 18, 2020
  • Coronavirus Legislative Update | March 16, 2020
  • The Public Readiness and Emergency Preparedness (PREP) Act: Liability Protection for Suppliers of COVID-19 Countermeasures | March 16, 2020

  Blog Posts

  • The European Commission proposes a Regulation for COVID-19 clinical trials conducted with medicinal products containing or consisting of GMOs | July 9, 2020
  • EU Medical Devices Regulation: implementation progress during the pandemic | June 18, 2020
  • EMA Guidance on fast-tracking the development and approval of treatments and vaccines for COVID-19 | May 7, 2020
  • UK Government Offers IP Indemnity to Designers and Manufacturers of Ventilators for COVID-19 Patients | April 24, 2020

  Webinars

  • EU and UK Compliance Considerations in Remote Promotion Training and Medical Information Services | July 2, 2020
  • Pharmaceutical and Medical Device Global Supply Chains Under a Microscope: Understanding and Managing the Growing Risks | June 25, 2020
  • Re-Opening Your Business in a COVID Environment: A Discussion on Protecting Consumers and Employees | June 22, 2020
  • FDA Inspection Alternatives During the COVID-19 Pandemic: Requesting, Preparing for, and Responding to an FDA Virtual Inspection | June 15, 2020
  • What Biopharmaceutical and Medical Device Companies Need to Know About Telemedicine and Patient Care | June 3, 2020
  • Navigating COVID-19 Related Congressional Investigations | May 21, 2020
  • Navigating Patient Needs Remotely: Addressing Challenges in Patient Access | May 20, 2020
  • FDA and Other Compliance Considerations in Remote Promotion, Training and Medical Information Services | May 13, 2020
  • COVID-19: Key Developments for FDA-Regulated Consumer Product Companies | April 1, 2020
  • Policy Developments Related to the Coronavirus Pandemic Part II: The CARES Act | March 27, 2020
  • COVID-19: Working With BARDA and FDA on COVID-19 Countermeasures | March 26, 2020
  • The Coronavirus Crisis: What Companies Need to Know About Congressional Actions to Date and the Likely Next Legislative Steps on the Road to Recovery | March 18, 2020
• Legislation

  Advisories

  • Paycheck Protection Program Flexibility Act | June 5, 2020
  • DC Council's Comprehensive Response to COVID-19: Key Provisions for the Real Estate Community | June 1, 2020
  • HEROES IN THE HOUSE: Congress Begins Consideration of a 5th COVID-19 Response Package Totaling $3 Trillion in New Spending | May 14, 2020
  • Federal Reserve Expands Main Street Lending Program | May 7, 2020
  • Fraud in the Time of COVID-19: White Collar and Regulatory Enforcement of the CARES Act | May 6, 2020
  • Veteran Mortgage Relief in the Era of COVID-19 | April 17, 2020
  • Personal Health Information Privacy and COVID-19: HIPAA and California Law Enforcement Forbearance April 8, 2020
  • Small Business Loan Relief From CARES Act | March 30, 2020
  • Analysis of CARES Act for Non-Profit Organizations March 27, 2020
  • Coronavirus Legislative Update: The CARES Act Becomes Law | March 26, 2020
  • Financial Regulators Encourage and Expect Firms to Continue Assisting Businesses During the Coronavirus Pandemic | March 17, 2020
  • Coronavirus Legislative Update | March 16, 2020
  • The Public Readiness and Emergency Preparedness (PREP) Act: Liability Protection for Suppliers of COVID-19 Countermeasures | March 16, 2020

  Webinars

  • CARES Act/Federal Reserve Act Section 13(3): Weekly Update 7 | June 26, 2020
  • Policymaker Speaker Series: Featuring US Representative Kurt Schrader (D-OR) | June 18, 2020
  • Policymaker Speaker Series: Featuring US Representative Don Beyer (D-VA) | June 17, 2020
  • CARES Act/Federal Reserve Act Section 13(3): Weekly Update 6 | June 12, 2020
  • CARES Act/Federal Reserve Act Section 13(3): Weekly Update 5 | June 5, 2020
  • Policymaker Speaker Series: Featuring US Representative Michael C. Burgess, MD (R-TX) | June 4, 2020
  • CARES Act/Federal Reserve Act Section 13(3): Weekly Update 4 | May 29, 2020
  • Policymaker Speaker Series: Featuring US Representative Cathy McMorris Rodgers (R-WA) | May 27, 2020
  • Policymaker Speaker Series: Featuring US Senator Jack Reed (D-RI) | May 26, 2020
  • CARES Act/Federal Reserve Act Section 13(3): Weekly Update 3 | May 22, 2020
  • Navigating COVID-19 Related Congressional Investigations | May 21, 2020
  • Policymaker Speaker Series: Featuring US Representatives Joyce Beatty (D-OH) and Steve Stivers (R-OH) | May 20, 2020
  • Understanding and Leveraging the Defense Production Act | May 18, 2020
  • CARES Act/Federal Reserve Act Section 13(3): Weekly Update 2 | May 15, 2020
  • Policymaker Speaker Series: Featuring US Senator Shelley Moore Capito (R-WV) | May 12, 2020
  • Policymaker Speaker Series Featuring US Senator Thom Tillis (R-NC) | May 11, 2020
  • CARES Act/Federal Reserve Act Section 13(3) Weekly Update: MSLP, PMCCF and PPP | May 8, 2020
  • Policymaker Speaker Series Featuring US Senator Steve Daines (R-MT) | May 6, 2020
  • Policymaker Speaker Series Featuring US Representative Dan Kildee (D-MI) | May 5, 2020
  • COVID-19: An Overview of Emergency Financing Facilities Created Under the Cares Act and Section 13(3) of the Federal Reserve Act | May 1, 2020
  • Policymaker Speaker Series Featuring US Representative Stephanie Murphy (D-FL) | April 28, 2020
  • The CARES Act: Provisions, Specifics, and Impact on Your Business | April 2, 2020
    Presented by Stifel Investment Banking, featuring Arnold & Porter's Senator Christopher Dodd, Dipanwita Deb Amar, Charles Yi, and Arturo Caraballo. Registration is required to watch the webinar; use password CARES20 to complete your registration.
  • Policy Developments Related to the Coronavirus Pandemic Part II: The CARES Act | March 27, 2020
  • The Coronavirus Crisis: What Companies Need to Know About Congressional Actions to Date and the Likely Next Legislative Steps on the Road to Recovery | March 18, 2020
• Non-Profits

  Advisories

  • Small Business Administration Releases New and Revised Loan Forgiveness Applications to Implement Terms of the Paycheck Protection Program Flexibility Act | June 24, 2020
  • University Preparedness for a Pandemic: Key Testing and Privacy Considerations Every University Should Be Aware Of | June 18, 2020
  • HEROES IN THE HOUSE: Congress Begins Consideration of a 5th COVID-19 Response Package Totaling $3 Trillion in New Spending | May 14, 2020
  • 2020 CARES Act—FAQs for Nonprofit Organizations and Donors | April 6, 2020
  • Analysis of CARES Act for Non-Profit Organizations | March 27, 2020
  • Coronavirus Nonprofit Update: Financial Assistance to Employees by Employer-Sponsored Philanthropy | March 17, 2020
• Real Estate and Hospitality

  Advisories

  • DC Council's Comprehensive Response to COVID-19: Key Provisions for the Real Estate Community |June 1, 2020
  • DC Council Commercial Real Estate Update | May 8, 2020
  • Commercial Real Estate Updates COVID-19 | April 23, 2020
  • Veteran Mortgage Relief in the Era of COVID-19 | April 17, 2020
  • Commercial Real Estate Updates COVID-19 | April 16, 2020
  • The Impact of Coronavirus on Existing Commercial Leases | March 24, 2020
  • The Coronavirus Crisis—Consider Your Contract Notice Provisions in Light of Office Closures | March 22, 2020
  • Coronavirus: Important Issues for Hospitality Industry Owners, Operators and Lenders | March 17, 2020
  • Coronavirus Legislative Update | March 16, 2020

  Webinars

  • Coronavirus: Important Issues for Hospitality Industry Owners, Operators and Lenders | March 18, 2020
  • The Coronavirus Crisis: What Companies Need to Know About Congressional Actions to Date and the Likely Next Legislative Steps on the Road to Recovery | March 18, 2020
• Tax

  Advisories

  • Paycheck Protection Program Flexibility Act | June 5, 2020
  • HEROES IN THE HOUSE: Congress Begins Consideration of a 5th COVID-19 Response Package Totaling $3 Trillion in New Spending | May 14, 2020
  • The CARES Act: Income Tax Provisions for Businesses | April 7, 2020
  • 2020 CARES Act—FAQs for Nonprofit Organizations and Donors | April 6, 2020
  • Analysis of CARES Act for Non-Profit Organizations | March 27, 2020
  • Coronavirus Legislative Update: The CARES Act Becomes Law | March 26, 2020
  • DOL Issues First Guidance on Paid Sick Leave and Expanded Family and Medical Leave Under the Families First Coronavirus Response Act | March 25, 2020
  • COVID-19: Tax Measures Package for Companies | March 23, 2020
  • Coronavirus Nonprofit Update: Financial Assistance to Employees by Employer-Sponsored Philanthropy | March 17, 2020